CTLA4 and cancer: With the recent understanding on the critical significance of Treg depletion by ADCC/ADCP, and the effort to improve ADCC/ADCP activities of the new antibodies, a timely issue is which cancer types are most suitable for testing the new generation of anti-CTLA-4 antibodies.